Nothing Special   »   [go: up one dir, main page]

AU2003283500A8 - 1,4-diazabicyclo(3.2.2)nonanecarboxamide derivatives, preparation and therapeutic use thereof related to malfunction of nicotinic receptors - Google Patents

1,4-diazabicyclo(3.2.2)nonanecarboxamide derivatives, preparation and therapeutic use thereof related to malfunction of nicotinic receptors

Info

Publication number
AU2003283500A8
AU2003283500A8 AU2003283500A AU2003283500A AU2003283500A8 AU 2003283500 A8 AU2003283500 A8 AU 2003283500A8 AU 2003283500 A AU2003283500 A AU 2003283500A AU 2003283500 A AU2003283500 A AU 2003283500A AU 2003283500 A8 AU2003283500 A8 AU 2003283500A8
Authority
AU
Australia
Prior art keywords
nonanecarboxamide
diazabicyclo
malfunction
derivatives
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2003283500A
Other versions
AU2003283500A1 (en
Inventor
Patrick Lardenois
Alistair Lochead
Odile Leclerc
Frederic Galli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France
Publication of AU2003283500A1 publication Critical patent/AU2003283500A1/en
Publication of AU2003283500A8 publication Critical patent/AU2003283500A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AU2003283500A 2002-10-08 2003-10-06 1,4-diazabicyclo(3.2.2)nonanecarboxamide derivatives, preparation and therapeutic use thereof related to malfunction of nicotinic receptors Abandoned AU2003283500A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0212500A FR2845388B1 (en) 2002-10-08 2002-10-08 1,4-DIAZABICYCLO [3.2.2] NONANECARBOXAMIDES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR02/12500 2002-10-08
PCT/FR2003/002929 WO2004033456A2 (en) 2002-10-08 2003-10-06 1,4-diazabicyclo[3.2.2]nonanecarboxamide derivatives, preparation and therapeutic use thereof related to malfunction of nicotinic receptors

Publications (2)

Publication Number Publication Date
AU2003283500A1 AU2003283500A1 (en) 2004-05-04
AU2003283500A8 true AU2003283500A8 (en) 2004-05-04

Family

ID=32011522

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003283500A Abandoned AU2003283500A1 (en) 2002-10-08 2003-10-06 1,4-diazabicyclo(3.2.2)nonanecarboxamide derivatives, preparation and therapeutic use thereof related to malfunction of nicotinic receptors

Country Status (9)

Country Link
EP (1) EP1575960B1 (en)
JP (1) JP4537853B2 (en)
AR (1) AR041527A1 (en)
AT (1) ATE425980T1 (en)
AU (1) AU2003283500A1 (en)
DE (1) DE60326757D1 (en)
FR (1) FR2845388B1 (en)
TW (1) TWI320413B (en)
WO (1) WO2004033456A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004309367B2 (en) 2003-12-22 2010-04-01 Memory Pharmaceuticals Corporation Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof
FR2865208B1 (en) * 2004-01-16 2009-01-16 Sanofi Synthelabo 1,4-DIAZABICYCLO [3.2.1] OCTANECARBOXMIQUE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF
NZ550534A (en) 2004-03-25 2009-07-31 Memory Pharm Corp Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
CA2567977A1 (en) * 2004-04-22 2006-01-05 Memory Pharmaceutical Corporation Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof
KR20070015607A (en) * 2004-05-07 2007-02-05 메모리 파마슈티칼스 코포레이션 1h-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof
CA2569887A1 (en) 2004-06-09 2005-12-22 Glaxo Group Limited Pyrrolopyridine derivatives
MX2007007328A (en) 2004-12-22 2007-07-25 Memory Pharm Corp Nicotinic alpha-7 receptor ligands and preparation and uses thereof.
EP1963332A1 (en) * 2005-11-09 2008-09-03 Memory Pharmaceuticals Corporation 1 h-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof
EP1842541A1 (en) * 2006-03-29 2007-10-10 G.I.M.-Gesellschaft Für Innovative Medizin Gmbh Nfg Ohg Plant components and extracts and uses thereof
CN101910170A (en) * 2007-10-22 2010-12-08 记忆药物公司 (1,4-diazabicyclo [3.2.2] ninth of the ten Heavenly Stems-6-alkene-4-yl)-heterocyclic radical-ketone part that is used for the treatment of the nicotinic acetylcholine receptor of disease
EP4259619A1 (en) * 2020-12-08 2023-10-18 Disarm Therapeutics, Inc. Benzopyrazole inhibitors of sarm1

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ226000A (en) * 1987-09-10 1991-06-25 Merck Sharp & Dohme Oxadiazolyl-azabicycloheptanes and pharmaceutical compositions
FR2786770B1 (en) * 1998-12-04 2001-01-19 Synthelabo NONANE 1,4-DIAZABICYCLO [3.2.2.] DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2804430B1 (en) * 2000-01-28 2002-03-22 Sanofi Synthelabo 4-HETEROARYL-1,4-DIAZABICYCLO [3.2.2] NONANE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2809730B1 (en) * 2000-05-31 2002-07-19 Sanofi Synthelabo 1,4-DIAZABICYCLO [3.2.2] NONANEBENZOXAZOLE, -BENZOTHIAZOLE AND -BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
US20020086871A1 (en) * 2000-12-29 2002-07-04 O'neill Brian Thomas Pharmaceutical composition for the treatment of CNS and other disorders

Also Published As

Publication number Publication date
ATE425980T1 (en) 2009-04-15
TW200505926A (en) 2005-02-16
JP4537853B2 (en) 2010-09-08
AU2003283500A1 (en) 2004-05-04
WO2004033456A2 (en) 2004-04-22
DE60326757D1 (en) 2009-04-30
EP1575960B1 (en) 2009-03-18
JP2006506356A (en) 2006-02-23
FR2845388A1 (en) 2004-04-09
AR041527A1 (en) 2005-05-18
FR2845388B1 (en) 2004-11-12
WO2004033456A3 (en) 2004-05-27
EP1575960A2 (en) 2005-09-21
TWI320413B (en) 2010-02-11

Similar Documents

Publication Publication Date Title
IL159275A0 (en) Phenylsulfonyl-1, 3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
HK1064090A1 (en) Xanthine derivative, production and use thereof asa medicament
IL173398A0 (en) Pyridyl derivatives and their use as therapeutic agents
IL153708A0 (en) Benzimidazole derivatives, preparation and therapeutic use thereof
HRP20041157B1 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
IL172733A0 (en) Diphenylpyridine derivatives, preparation and therapeutic application thereof
PT1525193E (en) Acylaminothiazole derivatives, preparation and therapeutic use thereof
TWI318974B (en) Acylaminothiazole derivatives, their preparation and their therapeutic use
AU2003283500A8 (en) 1,4-diazabicyclo(3.2.2)nonanecarboxamide derivatives, preparation and therapeutic use thereof related to malfunction of nicotinic receptors
DK1556382T3 (en) 3-Phenylpyridoindole derivatives, preparation and therapeutic use thereof
PL374858A1 (en) Novel arylimidazole derivatives, preparation and therapeutic uses thereof
IL162524A0 (en) Derivatives of (pyridin-3-yl)-1-azabicycloÄ3.2.1Ü octane, their preparation and their terapeutic application
HK1074444A1 (en) Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof
PL365342A1 (en) Mikanolide derivatives, their preparation and therapeutic uses
HK1065792A1 (en) 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino Ä4,5-BÜindole-1-carboxamide derivatives, their preparation and therapeutic use
AU2002237228A1 (en) Regulation of human adenylate cyclase, type vii
SI1474415T1 (en) 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, the use thereof for producing drugs used in the treatment of immunological diseases
SI1513835T1 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
SI1513836T1 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
SI1525198T1 (en) Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof
SI1525193T1 (en) Acylaminothiazole derivatives, preparation and therapeutic use thereof
AU1502902A (en) Regulation of human adenylate cyclase, type iv
IL165420A0 (en) Piperazinylacylpiperidine derivatives their preparation and therapeutic use thereof
GB0210898D0 (en) Pyridinecarbonitrile compounds and their therapeutic use
AU2002215029A1 (en) Regulation of human adenylate cyclase, type iv

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase